Carfilzomib + Elotuzumab + Dexamethasone for Relapsed Multiple Myeloma After 1-3 Prior Treatment Lines
Clinical trial NCT03155100 · COMPLETED
Trial details
- NCT number
- NCT03155100
- Sponsor
- Raija Silvennoinen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-07
- Primary completion
- 2023-08-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.